Related Experiment Video
Updated: May 25, 2026
10:30
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
[Exon-skipping therapy for Duchenne muscular dystrophy]
1Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry.
Rinsho Shinkeigaku = Clinical Neurology
|January 27, 2012
Summary
Antisense oligonucleotides can restore dystrophin in Duchenne muscular dystrophy (DMD) models. This study optimized exon skipping for DMD mutations, showing promise for treating this genetic disorder.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Context:
- Duchenne muscular dystrophy (DMD) results from dystrophin deficiency.
- Antisense oligonucleotides offer a therapeutic strategy by enabling exon skipping.
- Previous success was shown in canine DMD models.
Purpose:
- To optimize antisense oligonucleotides for frequent DMD mutations.
- To design and test Morpholino antisense oligonucleotides targeting exon 51 in mdx52 mice.
- To evaluate both local and systemic delivery of these therapeutic agents.
Summary:
- Antisense Morpholino oligonucleotides targeting exon 51 were designed for mdx52 mice.
- Mice received separate or combined injections into muscles.
- Systemic delivery of antisense Morpholino to skip exon 51 ameliorated phenotypes in mdx52 mice.
Impact:
- This research advances exon skipping as a therapeutic approach for Duchenne muscular dystrophy.
- The findings support ongoing clinical trials for exon 51 skipping in DMD patients.
- The antisense strategy shows potential for treating other hereditary neuromuscular diseases.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...